These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31621813)

  • 1. Unusual Vitreous Opacity in a Chinese Patient.
    Yu S; Xu Y; Liang X
    JAMA Ophthalmol; 2019 Dec; 137(12):1454-1455. PubMed ID: 31621813
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated vitreoretinal amyloidosis in the absence of transthyretin mutations.
    Barouch FC; Benson MD; Mukai S
    Arch Ophthalmol; 2004 Jan; 122(1):123-5. PubMed ID: 14718311
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
    Beirão NM; Matos E; Beirão I; Costa PP; Torres P
    Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
    Zou X; Dong F; Zhang S; Tian R; Sui R
    Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.
    Long D; Zeng J; Wu LQ; Tang LS; Wang HL; Wang H
    Ophthalmic Genet; 2012 Mar; 33(1):28-33. PubMed ID: 21843040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A; Rakic JM
    Rev Med Liege; 2013; 68(7-8):396-8. PubMed ID: 24053097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 9. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
    Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
    Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to suspect transthyretin amyloidosis in cases of isolated vitreous opacities?
    Poignet B; Cauquil C; Barreau E; Bodaghi B; Terrada C; Adams D; Francou B; Labetoulle M; Rousseau A
    Amyloid; 2020 Dec; 27(4):277-278. PubMed ID: 32500742
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunostaining images of vitreous transthyretin amyloid.
    Latasiewicz M; Adan A; Solé M
    Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid or asteroid?
    McLeod D; Bonshek R
    Arch Ophthalmol; 2005 Jun; 123(6):870; author reply 870-1. PubMed ID: 15955995
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristic Needle-Shaped Pattern Seen on OCT in a Patient with Ocular Amyloidosis.
    Tasiopoulou A; Ong D; Lightman S
    Ophthalmol Retina; 2021 Jan; 5(1):99-101. PubMed ID: 32683109
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
    Schweitzer K; Ehmann D; Garcia R; Alport E
    Can J Ophthalmol; 2009 Jun; 44(3):317-9. PubMed ID: 19491989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.
    Hara R; Kawaji T; Ando E; Ohya Y; Ando Y; Tanihara H
    Arch Ophthalmol; 2010 Feb; 128(2):206-10. PubMed ID: 20142544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
    Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
    Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
    Ciulla TA; Tolentino F; Morrow JF; Dryja TP
    Surv Ophthalmol; 1995; 40(3):197-206. PubMed ID: 8599155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary non familial amyloidosis of the vitreous and subretinal amyloid bodies.
    Rosenthal G; Walter P; Bartz-Schmidt KU; Heimann K
    Int Ophthalmol; 1999; 23(1):1-2. PubMed ID: 11008891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.